Consensus Celldex Therapeutics, Inc.

Equities

CLDX

US15117B2025

Delayed Nasdaq Other stock markets 04:00:00 2024-05-24 pm EDT			5-day change	1st Jan Change
36.92 ^USD	+1.65%		-3.38%	-6.91%

May. 15	Celldex Therapeutics Reports First Patient Dosed in Phase 2 Skin Disorder Study	MT
May. 15	Celldex Therapeutics, Inc. Announces First Patient Dosed in Phase 2 Study of Barzolvolimab in Prurigo Nodularis	CI

Evolution of the average Target Price on Celldex Therapeutics, Inc.

Price target over the last 5 years

History of analyst recommendation changes

1d5adf35bfc1201666c790b.1tiCtkmkqQJxTVcOtXB974UN3THLKwJgi-ecHrfec0I.jIH72CTr8HgoDhlR1z4riMM5l2uaE2At5N_DWYW5KRCGjNDAG_PzSTobDg~93700bfa06dcfc80d847415d09b47474

Analyst Recommendations on Celldex Therapeutics, Inc.

TD Cowen Initiates Celldex Therapeutics at Outperform Rating	Dec. 20	MT
Wells Fargo Upgrades Celldex Therapeutics to Equalweight From Underweight With $27 Price Target	Nov. 10	MT
HC Wainwright Adjusts Price Target on Celldex Therapeutics to $80 From $73, Maintains Buy Rating	Nov. 06	MT
Rate Cut Hopes Push Exchange-Traded Funds, Equity Futures Higher Pre-Bell Monday	Nov. 06	MT
Wells Fargo Starts Celldex Therapeutics With Underweight Rating, $21 Price Target	23-08-22	MT
ANALYST RECOMMENDATIONS : Applovin, BAE Systems, Evercore, Jefferies, Target...	23-08-22
Guggenheim Adjusts Price Target on Celldex Therapeutics to $63 From $68, Maintains Buy Rating	22-11-11	MT
SVB Securities Adjusts Celldex Therapeutics' Price Target to $64 From $68, Keeps Outperform Rating	22-08-09	MT
HC Wainwright Adjusts Celldex Therapeutics' Price Target to $73 from $60, Keeps Buy Rating	22-07-01	MT
CELLDEX THERAPEUTICS : Jefferies & Co Reinstates Coverage on Celldex Therapeutics With Buy Rating, $66 Price Target	21-09-17	MT
ANALYST RECOMMENDATIONS : Autoliv, Fortinet, Tesla, Virgin Galactic, WP Carey...	21-09-17
CELLDEX THERAPEUTICS : HC Wainwright Adjusts Celldex Therapeutics PT to $60 From $54, Maintains Buy Rating	21-09-13	MT
CELLDEX THERAPEUTICS : SVB Leerink Starts Celldex Therapeutics at Outperform with $68 Price Target	21-09-10	MT
CELLDEX THERAPEUTICS : HC Wainwright Adjusts Celldex Therapeutics' Price Target to $54 From $50, Reiterates Buy Rating	21-08-06	MT
CELLDEX THERAPEUTICS : Guggenheim Starts Celldex Therapeutics at Buy With $66 Price Target	21-07-22	MT
CELLDEX THERAPEUTICS : HC Wainwright Adjusts Price Target on Celldex Therapeutics to $50 From $36, Reiterates Buy Rating	21-07-12	MT
Celldex Therapeutics : Reports 80% Complete Response Rate in CDX-0159 Study	21-03-29	MT
Celldex Reports 80% Complete Response Rate in Interim Data Update from Phase 1b study of CDX-0159 in Chronic Inducible Urticaria	21-03-29	CI
CELLDEX THERAPEUTICS : HC Wainwright & Co. Adjusts Price Target on Celldex Therapeutics to $36 From $25, Maintains Buy Rating	21-02-23	MT
CELLDEX THERAPEUTICS : Cantor Fitzgerald Adjusts Celldex Therapeutics PT to $35 From $22, Maintains Overweight Rating	21-02-23	MT
Celldex Therapeutics, Inc. Announces Positive Results from a Phase 1 Multi-Dose Study of CDX-301	12-12-11	CI